Schrodinger, LLC

Based in the US, Schrodinger, LLC operates as a prominent provider of physics-based software solutions, focusing on molecular discovery and design for drug and materials development. Founded in 1990 and headquartered in New York, US, Schrodinger, LLC specializes in computational software for molecular research. The company completed a successful IPO in February 2020, raising USD 202 million by selling 11. 88 million shares.

The firm has engaged in six funding deals, with a total amount raised of USD 202 million. The current CEO is Ramy Farid. Schrödinger offers a physics-based software platform designed to facilitate molecular discovery and design across diverse sectors, particularly drug discovery and materials science. Key products include Maestro, Glide, FEP+, and LiveDesign, enabling researchers to discover and optimize molecules.

These tools are essential in applications such as small molecule drug discovery, biologics development, and materials optimization for various industries. Schrödinger serves a wide array of clients, including academic institutions and pharmaceutical companies, across North America, Europe, and Asia. In the most recent fiscal year 2024, Schrödinger reported a revenue of USD 207. 54 mn.

The company generates income through software licenses and subscriptions tailored for both academic and commercial users, with flagship products like Maestro and FEP+ integral to client agreements. Following its IPO in February 2020, Schrodinger intends to leverage the USD 202 million raised to enhance its product portfolio and expand into new markets. The company is focusing on the development of new software tools aimed at addressing evolving molecular research needs. Additionally, Schrodinger plans to increase its presence in European and Asian markets by 2025, enhancing accessibility to its solutions and fostering collaborations with local research institutions.